Abstract

Dear Editor:
We read with great interest the article by Salonia and colleagues, which reported increased levels of endothelin-1 (ET-1) in the cerebrospinal fluid (CSF) of children with severe traumatic brain injury (TBI), in association with unfavorable outcome. 1 The study was well conducted and the findings are intriguing. However, we wonder if the authors have considered the influence of the blood–CSF barrier (B-CSF-B) on the CSF level of ET-1.
ET-1 synthesis may be upregulated in cerebrovascular endothelium under pathological conditions.
2
The origin of ET-1 beyond endothelia in the CSF is still underclarified. As acknowledged by Salonia and colleagues, it would be better to measure both local (CSF) and systemic (serum) levels of ET-1. In terms of this limitation, the altered levels of ET-1 in the CSF of subjects with TBI may arise primarily from the leakage of serum ET-1 into the CSF through damaged B-CSF-B in TBI.
3
To correct for the B-CSF-B damage, and not allow the leakage of serum proteins into the CSF to influence the measured CSF levels of ET-1, the CSF/plasma index of ET-1 can be calculated as follows:
Only by doing this may the leakage of serum proteins into the CSF be adjusted to avoid the above-hypothesized confounding factor.
In summary, it is promising to find an increased level of ET-1 in the CSF of patients with severe TBI. Although the source of this elevation remains to be elucidated, the association of ET-1 with prognosis of TBI warrants more investigations.
